| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 11,056,000 | 11,236,000 | 10,373,000 | 11,132,000 | | Cost of Revenue | 10,060,000 | 10,224,000 | 9,368,000 | 9,865,000 | | | Gross Profit | 996,000 | 1,012,000 | 1,005,000 | 1,267,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative |
-
|
-
|
-
|
-
| | Non Recurring |
-
|
-
|
-
| (108,000) | | Others | (89,000) | (71,000) | (52,000) | 316,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,085,000 | 1,083,000 | 1,057,000 | 1,059,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 54,000 | 47,000 | (3,000) | (102,000) | | Earnings Before Interest And Taxes | 1,139,000 | 1,130,000 | 1,054,000 | 1,246,000 | | Interest Expense | 67,000 | 76,000 | 76,000 | 77,000 | | Income Before Tax | 1,072,000 | 1,054,000 | 978,000 | 1,169,000 | | Income Tax Expense | 275,000 | 320,000 | 312,000 | 346,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 797,000 | 734,000 | 666,000 | 823,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 797,000 | 734,000 | 666,000 | 823,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $797,000 | $734,000 | $666,000 | $823,000 |
|
0.01% Nasdaq 0.00%
Income Statement
